Bristol-Myers' Opdualag fails Phase 3 melanoma study
Bristol-Myers Squibb (NYSE:BMY) said that the Phase 3 RELATIVITY-098 study of its drug Opdualag in the treatment of late-stage melanoma didn't meet its primary endpoint. The drugmaker had been testing ...
Teddi Mellancamp’s Melanoma Battle: Her Health Now After Brain Tumor Discovery
The reality star, who was diagnosed with skin cancer in 2022, has now revealed that doctors have found multiple tumors on her ...
Onlymyhealth4d
From Your Lips To The Soles Of Your Feet, Unusual Places Where You Can Develop Skin Cancer
Skin cancer is a common type of cancer that can occur anywhere on the body Read to find out about the least expected areas ...
Medscape9d
Expert Tips on Mohs Surgery for Melanoma
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
Medscape23d
Diagnosis and Management of Malignant Tumors of the Eyelid, Conjunctiva, and Orbit
The embryonal form is the most common form of RMS and the alveolar form is the most malignant. The pleomorphic form is least common and occurs in adults. The botryoid form is associated with a ...
ascopubs.org29d
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan
Statistical significance was set at P < .05. Between October 2020 and May 2023, C-CAT registered CGP results from 569 patients with malignant melanoma (Table 1). The majority of samples were tissues ...